by Danielle Bonadies | Mar 26, 2015 | News
Ellen T. Matloff, My Gene Counsel President and CEO, was featured in Nature last week discussing how misinterpreted results of genetic testing for cancer risk can result in unnecessary surgery. This story follow’s Angelina Jolie Pitt’s disclosure that she...
by Danielle Bonadies | Feb 24, 2015 | Genetic Journal
A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time, at more than $4,000 a pop, in order to qualify for a new drug called...
by Danielle Bonadies | Dec 1, 2014 | Genetic Journal
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...
